GENEVA, March 9 -- GLIOGUARD S.R.L. (Via Flavia, 23/1I-34148 Trieste (TS)) filed a patent application (PCT/IB2025/058540) for "A COMBINATION OF R-KETOROLAC, BUMETANIDE AND NIFLUMIC" on Aug 25, 2025. With publication no. WO/2026/047515, the details related to the patent application was published on Mar 05, 2026.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Inventor(s): TORRE, Vincent (c/oGlioguard S.r.l.Via Flavia 23/1I-34148 Trieste (TS))
Abstract: The present invention relates to a pharmaceutical composition for use in the treatment of both low-grade and high-grade glioblastoma in a human subject. The com...